Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Correction: Population pharmacokinetics model of pyrazinamide to optimize tuberculosis treatment: An interethnic cohort study of diabetes mellitus effect on drug exposure

  • Rannissa Puspita Jayanti,
  • Yong-Soon Cho,
  • Soedarsono Soedarsono,
  • Hyo-Jung Kim,
  • Jiyeon Kang,
  • Jehun Kim,
  • Jee Youn Oh,
  • Bo Hyoung Kang,
  • Jick Hwan Ha,
  • Jin-Woo Kim,
  • Ni Made Mertaniasih,
  • Tutik Kusmiati,
  • Ariani Permatasari,
  • Rika Yuliwulandari,
  • Ryunha Kim,
  • Hyeon-Jeong Seong,
  • Jong-Lyul Ghim,
  • Dong-Hyun Kim,
  • Jae-Gook Shin,
  •  [ ... ],
  • on behalf of the cPMTb
  • [ view all ]
  • [ view less ]

The Funding statement for this article is incorrect. The correct Funding statement is as follows: This work was supported by a National Research Foundation of Korea grant funded by the Ministry of Science and ICT of Republic of Korea [grant numbers No.2018R1A5A2021242, No. 2021R1F1A1056393] to J.G.S and Y.S.C, respectively; a grant from the Ministry of Research and Technology/National Agency for Research and Innovation of Indonesia [grant numbers 8478/UN3.1.1/LT/2019] to S.S; and a grant from the National Institute of Health (NIH) of Republic of Korea [grant numbers No. 2024ER200201] to Y.S.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.

Reference

  1. 1. Jayanti RP, Cho Y-S, Soedarsono S, Kim H-J, Kang J, Kim J, et al. Population pharmacokinetics model of pyrazinamide to optimize tuberculosis treatment: An interethnic cohort study of diabetes mellitus effect on drug exposure. PLoS One. 2026;21(1):e0340133. pmid:41610100